Dickinson, L., Amin, J., Else, L., Boffito, M., Egan, D., Owen, A., . . . Emery, S. (2015). Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study. Clin Pharmacol Ther.
Chicago Style citaatDickinson, L., et al. "Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 Mg Vs. 600 Mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study." Clin Pharmacol Ther 2015.
MLA citatieDickinson, L., et al. "Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 Mg Vs. 600 Mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study." Clin Pharmacol Ther 2015.
Let op: Deze citaties zijn niet altijd 100% accuraat.